This inventor holds 1 USPTO granted patent. Top assignees: Keio University, Sun Pharma Japan Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 361 
1 out of 1 Years Active: 2022
Title: Nobuo Kubota: Innovator in Cancer Research
Introduction
Nobuo Kubota is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research, particularly in the development of pharmaceutical solutions aimed at suppressing cancer stem cells. His innovative approach has the potential to impact cancer treatment significantly.
Latest Patents
Nobuo Kubota holds a patent for a cancer stem cell inhibitor. The object of this invention is to provide a novel pharmaceutical for suppressing cancer stem cells. The invention utilizes a mitochondria inhibitor comprising a 2-nitroimidazole derivative as an active ingredient, targeting cancer stem cells effectively.
Career Highlights
Throughout his career, Nobuo Kubota has worked with esteemed institutions such as Keio University and Sun Pharma Japan Limited. His work in these organizations has allowed him to collaborate with other experts in the field and advance his research in cancer treatment.
Collaborations
Some of his notable coworkers include Oltea Sampetrean and Hideyuki Saya. Their collaborative efforts have contributed to the development of innovative solutions in cancer research.
Conclusion
Nobuo Kubota's work in cancer stem cell research exemplifies the importance of innovation in the medical field. His contributions have the potential to lead to breakthroughs in cancer treatment, showcasing the vital role of inventors in advancing healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile